Sophia Randolph
2022
In 2022, Sophia Randolph earned a total compensation of $2.1M as Chief Medical Officer at ALX ONCOLOGY HOLDINGS, a 56% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $165,908 |
|---|---|
| Option Awards | $1,022,942 |
| Salary | $471,330 |
| Stock Awards | $424,390 |
| Total | $2,084,570 |
Randolph received $1M in option awards, accounting for 49% of the total pay in 2022.
Randolph also received $165.9K in non-equity incentive plan, $471.3K in salary and $424.4K in stock awards.
Rankings
In 2022, Sophia Randolph's compensation ranked 1,700th out of 5,760 executives tracked by ExecPay. In other words, Randolph earned more than 70.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,700 out of 5,760 | 71st |
Division Manufacturing | 890 out of 3,136 | 72nd |
Major group Chemicals And Allied Products | 359 out of 1,422 | 75th |
Industry group Drugs | 328 out of 1,323 | 75th |
Industry Pharmaceutical Preparations | 234 out of 969 | 76th |
Source: SEC filing on April 24, 2023.
Randolph's colleagues
We found two more compensation records of executives who worked with Sophia Randolph at ALX ONCOLOGY HOLDINGS in 2022.